These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6210296)

  • 1. Reversed-phase paired-ion high-performance liquid chromatographic method for the separation and quantification of multiple bleomycin congeners.
    Klett RP; Chovan JP; Danse IH
    J Chromatogr; 1984 Oct; 310(2):361-71. PubMed ID: 6210296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of bleomycins.
    Fiedler HP; Wachter J
    J Chromatogr; 1991 Jan; 536(1-2):343-7. PubMed ID: 1711052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of components of bleomycin preparations.
    Aszalos A; Crawford J; Vollmer P; Kantor N; Alexander T
    J Pharm Sci; 1981 Aug; 70(8):878-80. PubMed ID: 6171636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bleomycin-induced pulmonary toxicity and related factors to that toxicity in experimental animals].
    Okayama H
    Tsurumi Shigaku; 1986 May; 12(2):245-57. PubMed ID: 2429414
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and quantification of bleomycin in serum and tumor tissue by liquid chromatography coupled to high resolution mass spectrometry.
    Kosjek T; Krajnc A; Gornik T; Zigon D; Groselj A; Sersa G; Cemazar M
    Talanta; 2016 Nov; 160():164-171. PubMed ID: 27591601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.
    Mahdadi R; Kenani A; Pommery N; Pommery J; Hénichart JP; Lhermitte M
    Cancer Chemother Pharmacol; 1991; 28(1):22-6. PubMed ID: 1710176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of bleomycin hydrolase with a monoclonal antibody and its characterization.
    Nishimura C; Tanaka N; Suzuki H; Tanaka N
    Biochemistry; 1987 Mar; 26(6):1574-8. PubMed ID: 3109467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous phase high speed liquid chromatographic separation and atomic absorption detection of amino carboxylic acid--copper chelates.
    Jones DR; Manahan SE
    Anal Chem; 1976 Mar; 48(3):502-5. PubMed ID: 814842
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of bleomycin hydrolase.
    Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
    Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-performance-liquid-chromatographic method for the assay of coproporphyrinogen oxidase activity in rat liver.
    Li F; Lim CK; Peters TJ
    Biochem J; 1986 Oct; 239(2):481-4. PubMed ID: 3814086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin hydrolase is a unique thiol aminopeptidase.
    Nishimura C; Suzuki H; Tanaka N; Yamaguchi H
    Biochem Biophys Res Commun; 1989 Sep; 163(2):788-96. PubMed ID: 2506856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic inactivation of bleomycin analogs by bleomycin hydrolase.
    Sebti SM; Lazo JS
    Pharmacol Ther; 1988; 38(3):321-9. PubMed ID: 2461572
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereoselective analysis of D and L dansyl amino acids as the mixed chelate copper(II) complexes by HPLC.
    Lam S
    J Chromatogr Sci; 1984 Sep; 22(9):416-23. PubMed ID: 6490790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
    Filderman AE; Genovese LA; Lazo JS
    Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine strain differences in pulmonary bleomycin metabolism.
    Filderman AE; Lazo JS
    Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase.
    Sebti SM; DeLeon JC; Lazo JS
    Biochemistry; 1987 Jul; 26(14):4213-9. PubMed ID: 3117099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.